...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Message: $2.72 just 4 more cents for a new 52 week high....

$2.08 on the OTC for a new 52 week high today already.....

And the board has gone dead...there's lots more positing when the PPS is struggling, which goes to show the power of FUD imo.

New Message
Please login to post a reply